Financial Engines Advisors L.L.C. Regeneron Pharmaceuticals, Inc. Transaction History

Financial Engines Advisors L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $520,236 - $628,590	-955 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $230,380 - $300,710	467 Added 95.7%	955 $596,000
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $164,055 - $241,281	488 New	488 $238,000
Q1 2018 May 02, 2018	SELL	$315.82 - $393.78 $631 - $787	-2 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$358.63 - $469.95 $717 - $939	2	2 $1,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Financial Engines Advisors L.L.C., based on Form 13F filings with the SEC.

Stay updated on Financial Engines Advisors L.L.C. with notifications on news.